Keppra is a drug used to treat a variety of neurological conditions, including epilepsy. It is a commonly prescribed medication, but there are potential side effects that many people are unaware of. This article will explore the unseen side of Keppra and uncover the potentially severe side effects associated with its use.
Keppra is a brand name for the drug levetiracetam. It is an anticonvulsant medication used to treat partial-onset seizures, tonic-clonic seizures, and myoclonic seizures in adults and children over the age of four. It is also sometimes used to treat bipolar disorder. Keppra works by reducing the activity of certain chemicals in the brain that can cause seizures. It is generally considered to be a safe and effective medication, but it is important to be aware of the potential side effects.
The most common side effects of Keppra include: • Drowsiness • Fatigue • Nausea • Dizziness • Headache • Weight gain • Vomiting • Diarrhea • Difficulty sleeping • Irritability • Anxiety • Depression • Memory problems • Tremors • Visual disturbances These side effects are usually mild and do not require medical attention. However, if they are severe or persist, contact your doctor.
Keppra can also cause more serious side effects, including: • Difficulty breathing • Swelling of the face, lips, tongue, or throat • Hives • Skin rash • Blurred vision • Confusion • Hallucinations • Uncontrollable shaking • Severe dizziness • Unusual bleeding or bruising • Severe abdominal pain • Unusual tiredness or weakness • Yellowing of the skin or eyes If you experience any of these side effects, contact your doctor immediately.
Certain people may be more likely to experience side effects from Keppra. These include people with kidney or liver disease, people who are pregnant or breastfeeding, and people who are taking other medications. It is important to tell your doctor about any medications you are taking, as well as any medical conditions you may have, before starting Keppra.
Keppra can interact with certain medications, including anticoagulants, antidepressants, antihistamines, and anticonvulsants. It can also interact with certain supplements, such as St. John’s Wort. It is important to tell your doctor about any medications or supplements you are taking before starting Keppra.
Keppra is a commonly prescribed medication used to treat a variety of neurological conditions. While it is generally considered to be safe and effective, it can cause serious side effects. It is important to be aware of the potential side effects of Keppra and to talk to your doctor about any medications or supplements you are taking before starting the medication. By being aware of the potential side effects, you can ensure that Keppra is used safely and effectively.
1.
When Should Immunocompromised Individuals Receive a COVID Booster?
2.
Home Screening Appeals to Women Facing Healthcare Barriers
3.
Quality of Life Similar With Proton Beam Therapy vs IMRT for Prostate Cancer
4.
Prolonged Screen Time Linked to Sleep Issues in Preschoolers
5.
Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents
1.
Rehabilitation After Organ-Conserving Cancer Surgery
2.
Revolutionizing Oncology: AI in Radiology, Machine Learning in Pathology, and Deep Learning for Cancer Detection
3.
Artificial Intelligence for Bone Marrow Cellular Ecosystem Modeling
4.
Thyroid Cancer and Insulin Resistance: Unraveling the Complex Interplay for Better Patient Outcomes
5.
Mastering Breast Cancer Care in 2025: Diagnosis, Treatment, Education, and Innovation
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part XIII
2.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
5.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation